(Q34300348)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978513%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

review article

1 reference

title

Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978513%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference

1 reference

Joris C Verster

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978513%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Edmund R Volkerts

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978513%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978513%20AND%20SRC:MED&resulttype=core&format=json

CNS Neuroscience & Therapeutics

24 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978513%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978513%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978513%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

page(s)

45-76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978513%20AND%20SRC:MED&resulttype=core&format=json

Interaction of propoxyphene with diazepam, alprazolam and lorazepam

24 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Alprazolam as an alternative to low-dose haloperidol in older, cognitively impaired nursing facility patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Surreptitious drug use by patients in a panic disorder study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

A double-blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

The effects of alprazolam and buspirone in light and moderate female social drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Treatment of premenstrual dysphoria with alprazolam. A controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Use of alprazolam for relief of tinnitus. A double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Influence of menstrual cycle and gender on alprazolam pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

The effects of depression and anxiety on memory performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Overview of the Cross-National Collaborative Panic Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Pharmacodynamic evaluation of the benzodiazepine-oral contraceptive interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Tolerance to alprazolam after intravenous bolus and continuous infusion: psychomotor and EEG effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Do alprazolam-induced changes in saccadic eye movement and psychomotor function follow the same time course?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Etizolam in the treatment of generalized anxiety disorder associated with depressive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

A controlled clinical trial of alprazolam for the treatment of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Depressive symptoms and neurocognitive test scores in patients passing symptom validity tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Clinical aspects of chronic use of alprazolam and lorazepam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Effects of acute and chronic alprazolam treatment on cerebral blood flow, memory, sedation, and plasma catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Alprazolam vs amitriptyline in depressions with reduced REM latencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Alprazolam in end-stage renal disease. II. Pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Long-term Treatment of Anxiety and Risk of Withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2004.TB00003.X

Long-term effects of alprazolam on memory: a 3.5 year follow-up of agoraphobia/panic patients

21 January 2018

1 reference

12 December 2020

Recent advances in the pharmacological treatment of tinnitus

1 reference

12 December 2020

Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans

1 reference

12 December 2020

Psychomotor performance of long-term benzodiazepine users before, during, and after benzodiazepine discontinuation

1 reference

12 December 2020

Food "cravings" and the acute effects of alprazolam on food intake in women with premenstrual dysphoric disorder.

1 reference

12 December 2020

Influence of endogenous progesterone on alprazolam pharmacodynamics

1 reference

12 December 2020

Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.

1 reference

12 December 2020

Psychomotor performance and monoamine function in bipolar and unipolar affective disorders

1 reference

12 December 2020

Characteristics of placebo responses in medical treatment of premenstrual syndrome

1 reference

12 December 2020

Psychological strategies for discontinuing benzodiazepine treatment

1 reference

12 December 2020

Predictors of individual differences in alprazolam self-medication.

1 reference

12 December 2020

New insights into the mechanism of action of hypnotics

1 reference

12 December 2020

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology

1 reference

12 December 2020

Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam

1 reference

12 December 2020

Increased sensitivity to alprazolam in females with a paternal history of alcoholism

1 reference

12 December 2020

Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam

1 reference

12 December 2020

Correlation between coefficient of variation of choice reaction time and components of event-related potentials (P300): effect of benzodiazepine

1 reference

12 December 2020

A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam

1 reference

12 December 2020

Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group

1 reference

12 December 2020

Behavioral and subjective effects of DN-2327 (pazinaclone) and alprazolam in normal volunteers

1 reference

12 December 2020

Open study of effects of alprazolam on seasonal affective disorder

1 reference

12 December 2020

Absence of neuropsychologic deficits in patients receiving long-term treatment with alprazolam-XR for panic disorder

1 reference

12 December 2020

GABA(A) receptor subtypes: dissecting their pharmacological functions

1 reference

12 December 2020

New alternative agents in essential tremor therapy: double-blind placebo-controlled study of alprazolam and acetazolamide

1 reference

12 December 2020

A benzodiazepine mood effect scale: reliability and validity determined for alcohol-dependent subjects and adults with a parental history of alcoholism

1 reference

12 December 2020

Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.

1 reference

12 December 2020

Effects of Commonly Used Benzodiazepines on the Fetus, the Neonate, and the Nursing Infant

1 reference

12 December 2020

Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study

1 reference

12 December 2020

What to do when SSRIs fail: eight strategies for optimizing treatment of panic disorder.

1 reference

12 December 2020

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders

1 reference

12 December 2020

Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?

1 reference

12 December 2020

Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia

1 reference

12 December 2020

Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia

1 reference

12 December 2020

Fluoxetine impairs clearance of alprazolam but not of clonazepam

1 reference

12 December 2020

Characteristics of long-term alprazolam users in the community

1 reference

12 December 2020

Discontinuation of alprazolam after long-term treatment of panic-related disorders

1 reference

12 December 2020

A meta-analysis of treatments for panic disorder with agoraphobia: imipramine, alprazolam, and in vivo exposure

1 reference

12 December 2020

Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: some trait anxiety-independent responses

1 reference

12 December 2020

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of sublingual and oral alprazolam in the post-prandial state

1 reference

12 December 2020

Pharmacokinetics of alprazolam in elderly patients with multiple diseases

1 reference

12 December 2020

Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders

1 reference

12 December 2020

Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators

1 reference

12 December 2020

Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients

1 reference

12 December 2020

A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder

1 reference

12 December 2020

The effects of alprazolam alone and combined with alcohol on central integrative activity

1 reference

12 December 2020

A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly

1 reference

12 December 2020

Benzodiazepines, memory and mood: a review

1 reference

12 December 2020

Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I).

1 reference

12 December 2020

An open label trial of alprazolam in comorbid irritable bowel syndrome and generalized anxiety disorder.

1 reference

12 December 2020

A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.

1 reference

12 December 2020

A comparison of the single-dose effects of alprazolam, buspirone, and placebo upon memory function.

1 reference

12 December 2020

Long-term alprazolam use: abuse, dependence or treatment?

1 reference

12 December 2020

Disposition of alprazolam in human volunteers. Differences between genders

1 reference

12 December 2020

Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder

1 reference

12 December 2020

Pharmacokinetics of Alprazolam in Geriatric Patients with Neurotic Depression

1 reference

12 December 2020

Alprazolam in end-stage renal disease: I. Pharmacokinetics

1 reference

12 December 2020

Alprazolam and oxazepam in the treatment of anxious out-patients with depressive symptoms: a double-blind multicenter study

1 reference

12 December 2020

Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine.

1 reference

12 December 2020

The effects of a single oral dose of lorazepam and alprazolam on reaction times in young healthy volunteers

1 reference

12 December 2020

1 reference

12 December 2020

Panic patients in the non-panic state: physiological and cognitive dysfunction

1 reference

12 December 2020

Benzodiazepines and human memory: a review.

1 reference

12 December 2020

The effects of alprazolam, quazepam and diazepam on saccadic eye movements, parameters of psychomotor function and the EEG.

1 reference

12 December 2020

Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder

1 reference

12 December 2020

Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study

1 reference

12 December 2020

A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms

1 reference

12 December 2020

Prescription-event monitoring of 10,895 patients treated with alprazolam.

1 reference

12 December 2020

Alprazolam levels and response in panic disorder: preliminary results

1 reference

12 December 2020

The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects.

1 reference

12 December 2020

Alprazolam and amitriptyline in the treatment of major depressive disorder: a double-blind clinical and sleep EEG study

1 reference

12 December 2020

Lorazepam vs. alprazolam in the treatment of panic disorder

1 reference

12 December 2020

Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial

1 reference

12 December 2020

Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic effects of a single nocturnal dose of alprazolam

1 reference

12 December 2020

Comparison of the relationship between structure and CNS effects for lorazepam, clonazepam and alprazolam

1 reference

12 December 2020

Treatment effects of alprazolam and imipramine: physiological versus subjective changes in patients with generalized anxiety disorder

1 reference

12 December 2020

Effects of single doses of alprazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.

1 reference

12 December 2020

A comparison of alprazolam and behavior therapy in treatment of panic disorder

1 reference

12 December 2020

Alprazolam in the elderly: pharmacokinetics and pharmacodynamics during multiple dosing

1 reference

12 December 2020

The relationship of alprazolam dose to steady-state plasma concentrations.

1 reference

12 December 2020

Effects of 1 week administration of two benzodiazepines on the sleep and early daytime performance of normal subjects

1 reference

12 December 2020

Response of panic disorder to fixed doses of alprazolam or imipramine.

1 reference

12 December 2020

Benzodiazepines and vigilance performance: a review

1 reference

12 December 2020

Etizolam in the treatment of generalized anxiety disorder: a controlled clinical trial

1 reference

12 December 2020

Double blind comparison of alprazolam with dosulepine in endogenous depression.

1 reference

12 December 2020

Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders

1 reference

12 December 2020

Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of alprazolam following single and multiple oral doses of a sustained-release formulation

1 reference

12 December 2020

A comparison of alprazolam with amitriptyline in the treatment of patients with neurotic or reactive depression. A report of a randomised, double blind study by a General Practitioner Working Party

1 reference

12 December 2020

Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.

1 reference

12 December 2020

An evaluation of alprazolam in the treatment of reactive or neurotic (secondary) depression

1 reference

12 December 2020

Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam

1 reference

12 December 2020

Psychomotor effects of alprazolam and diazepam during acute and subacute treatment, and during the follow-up phase.

1 reference

12 December 2020

Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects

1 reference

12 December 2020

Chronic use of benzodiazepines and psychomotor and cognitive test performance

1 reference

12 December 2020

Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients

1 reference

12 December 2020

A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.

1 reference

12 December 2020

Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study

1 reference

12 December 2020

Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.

1 reference

12 December 2020

Benzodiazepine pharmacodynamics: evidence for biophase rate limiting mechanisms.

1 reference

12 December 2020

Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone

1 reference

12 December 2020

Alprazolam compared to clobazam and placebo in anxious outpatients.

1 reference

12 December 2020

Alprazolam versus imipramine in depressed out-patients with neurovegetative signs

1 reference

12 December 2020

Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms

1 reference

12 December 2020

A comparison of the efficacy and safety of alprazolam and desipramine in depressed outpatients

1 reference

12 December 2020

Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effects

1 reference

12 December 2020

A double blind comparison of alprazolam and amitriptyline hydrochloride in the treatment of nonpsychotic depression

1 reference

12 December 2020

Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial

1 reference

12 December 2020

Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients

1 reference

12 December 2020

Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone

1 reference

12 December 2020

Implications of restrictive diagnosis for compliance to antidepressant drug therapy: alprazolam versus imipramine

1 reference

12 December 2020

Anxiolytics and memory: a comparison of lorazepam and alprazolam.

1 reference

12 December 2020

A double-blind study of alprazolam and oxazepam in the treatment of anxiety

1 reference

12 December 2020

Alprazolam compared to amitriptyline in the treatment of major depression

1 reference

12 December 2020

Alprazolam kinetics following sublingual and oral administration

1 reference

12 December 2020

Alprazolam and lorazepam single and multiple-dose effects on psychomotor skills and sleep

1 reference

12 December 2020

Taper withdrawal studies with alprazolam in patients with panic disorder and agoraphobia.

1 reference

12 December 2020

An open comparison of diazepam and alprazolam.

1 reference

12 December 2020

Effects of alprazolam and diazepam on the daytime sleepiness of non-anxious subjects

1 reference

12 December 2020

Anxiolytic efficacy of alprazolam compared to diazepam and placebo.

1 reference

12 December 2020

Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients

1 reference

12 December 2020

A double-blind study of alprazolam and lorazepam in the treatment of anxiety

1 reference

12 December 2020

Alprazolam kinetics in the elderly. Relation to antipyrine disposition

1 reference

12 December 2020

Comparison of Alprazolam, Imipramine, and Placebo in the Treatment of Depression

1 reference

12 December 2020

Interaction of cimetidine with the triazolobenzodiazepines alprazolam and triazolam

1 reference

12 December 2020

A double blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients

1 reference

12 December 2020

A double-blind comparison of alprazolam Vs. imipramine and placebo in the treatment of major depressive disorder

1 reference

12 December 2020

Alprazolam and amitryptyline: a double blind comparison of anxiolytic and anti-depressant activity

1 reference

12 December 2020

Some Biochemical Correlates of Panic Attacks with Agoraphobia and Their Response to a New Treatment

1 reference

12 December 2020

Alprazolam Pharmacokinetics in Alcoholic Liver Disease

1 reference

12 December 2020

Long-Term Comparison of Alprazolam, Lorazepam and Placebo in Patients with an Anxiety Disorder

1 reference

12 December 2020

Alprazolam and lorazepam effects on memory acquisition and retrieval processes.

1 reference

12 December 2020

Double-blind comparison of alprazolam versus imipramine in the inpatient treatment of major depressive illness

1 reference

12 December 2020

Alprazolam and diazepam in the treatment of generalized anxiety

1 reference

12 December 2020

Double-blind controlled trial comparing alprazolam and lorazepam in ambulatory anxious patients

1 reference

12 December 2020

Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration

1 reference

12 December 2020

Evaluating drug effects on children's cognitive functioning

1 reference

12 December 2020

Serum dopamine-beta-hydroxylase activity in depression and anxiety.

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men

1 reference

12 December 2020

Alprazolam compared to diazepam and placebo in the treatment of anxiety.

1 reference

12 December 2020

Double-blind comparison of alprazolam and diazepam for subchronic withdrawal from alcohol

1 reference

12 December 2020

Diazepam impairs lateral position control in highway driving.

1 reference

12 December 2020

Treatment of depressive outpatients with lorazepam, alprazolam, amytriptyline and placebo

1 reference

12 December 2020

Comparison of the spectrum of cognitive effects of alprazolam and adinazolam after single doses in healthy subjects

1 reference

12 December 2020

Comparison of acute alprazolam (0.25, 0.50 and 1.0 mg) effects versus those of lorazepam 2 mg and placebo on memory in healthy volunteers using laboratory and telephone tests

1 reference

12 December 2020

Alprazolam for Tinnitus

1 reference

12 December 2020

Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis

1 reference

12 December 2020

Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder

1 reference

12 December 2020

Vigilance impairment after a single dose of benzodiazepines

1 reference

12 December 2020

Alprazolam absorption kinetics affects abuse liability*

1 reference

12 December 2020

Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity

1 reference

12 December 2020

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

1 reference

12 December 2020

Comparative abuse liability of sertraline, alprazolam, and dextroamphetamine in humans.

1 reference

12 December 2020

A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome

1 reference

12 December 2020

Safety and side-effects of alprazolam. Controlled study in agoraphobia with panic disorder

1 reference

12 December 2020

Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.

1 reference

12 December 2020

Memory functions, alprazolam and exposure therapy: a controlled longitudinal study of agoraphobia with panic disorder

1 reference

12 December 2020

Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans

1 reference

12 December 2020

Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes

1 reference

12 December 2020

A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine.

1 reference

12 December 2020

Alprazolam in the treatment of two subsamples of patients with late luteal phase dysphoric disorder: a double-blind, placebo-controlled crossover study

1 reference

12 December 2020

Long-term fluoxetine treatment of late luteal phase dysphoric disorder.

1 reference

12 December 2020

Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto

1 reference

12 December 2020

Comment on the London/Toronto Study of Alprazolam and Exposure in Panic Disorder with Agoraphobia

1 reference

12 December 2020

Maintenance drug therapy of panic disorder

1 reference

12 December 2020

Predictors of response to alprazolam and placebo in patients with panic disorder

1 reference

12 December 2020

Alprazolam and amitriptyline in the treatment of moderate depression

1 reference

12 December 2020

Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo

1 reference

12 December 2020

A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature

1 reference

12 December 2020

Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.

1 reference

12 December 2020

Alprazolam and benzodiazepine dependence

1 reference

12 December 2020

Alprazolam and depression: a review of risks and benefits

1 reference

12 December 2020

A study of pharmacokinetic interaction between buspirone and alprazolam at steady state

1 reference

12 December 2020

Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder

1 reference

12 December 2020

Three-year follow-up of patients with panic disorder after short-term treatment with alprazolam and imipramine

1 reference

12 December 2020

Rapid relief of anxiety in cancer patients with both alprazolam and placebo.

1 reference

12 December 2020

Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder

1 reference

12 December 2020

The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study

1 reference

12 December 2020

Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder

1 reference

12 December 2020

Discontinuation of benzodiazepine treatment: efficacy of cognitive- behavioral therapy for patients with panic disorder

1 reference

12 December 2020

Drug treatment of panic disorder. Further comment.

1 reference

12 December 2020

The combination of alprazolam and alcohol on behavioral aggression.

1 reference

12 December 2020

Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper

1 reference

12 December 2020

Alprazolam in panic disorder: a retrospective analysis

1 reference

12 December 2020

Clinical pharmacokinetics of alprazolam. Therapeutic implications

1 reference

12 December 2020

Benzodiazepines as antidepressants: does GABA play a role in depression?

1 reference

12 December 2020

A comparative study of the psychological effects of DN-2327, a partial benzodiazepine agonist, and alprazolam.

1 reference

12 December 2020

A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism.

1 reference

12 December 2020

Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects

1 reference

12 December 2020

Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam

1 reference

12 December 2020

Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam

1 reference

12 December 2020

Diazepam versus alprazolam for the treatment of panic disorder.

1 reference

12 December 2020

Alprazolam and suicidal ideation: a meta-analysis of controlled trials in the treatment of depression

1 reference

12 December 2020

Long-term follow-up after a drug trial for panic disorder

1 reference

12 December 2020

Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment.

1 reference

12 December 2020

Effects of alprazolam and bromazepam on visual search and verbal recognition memory in humans: a study with event-related brain potentials

1 reference

12 December 2020

Predictors of quality of life in a long-term followup study in panic disorder patients after a clinical drug trial

1 reference

12 December 2020

Effects of alprazolam and lorazepam on catecholaminergic and cardiovascular activity during supine rest, mental load and orthostatic challenge.

1 reference

12 December 2020

Effects of genetically determined S-mephenytoin 4-hydroxylation status and cigarette smoking on the single-dose pharmacokinetics of oral alprazolam

1 reference

12 December 2020

Alterations in pharmacodynamics of anxiolytics in abstinent alcoholic men: subjective responses, abuse liability, and electroencephalographic effects of alprazolam, diazepam, and buspirone.

1 reference

12 December 2020

Nonlinear mixed effects modeling of single dose and multiple dose data for an immediate release (IR) and a controlled release (CR) dosage form of alprazolam

1 reference

12 December 2020

Pharmacokinetics and psychomotor performance of alprazolam: concentration-effect relationship

1 reference

12 December 2020

Alprazolam and standard antidepressants in the treatment of depression: a meta-analysis of the antidepressant effect.

1 reference

12 December 2020

Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effects.

1 reference

12 December 2020

Acute participant-rated and behavioral effects of alprazolam and buspirone, alone and in combination with ethanol, in normal volunteers.

1 reference

12 December 2020

Acute and delayed effects of alprazolam on flight phobics during exposure.

1 reference

12 December 2020

Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group

1 reference

12 December 2020

Amnestic and anxiolytic effects of alprazolam in oral surgery patients.

1 reference

12 December 2020

A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group

1 reference

12 December 2020

Depression and memory in the elderly: a meta-analysis

1 reference

12 December 2020

Medication side effects in anxious patients: negative placebo responses?

1 reference

12 December 2020

Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria

1 reference

12 December 2020

Lack of multiple dosing effect of sertindole on the pharmacokinetics of alprazolam in healthy volunteers

1 reference

12 December 2020

Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial

1 reference

12 December 2020

Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam

1 reference

12 December 2020

A controlled trial of ondansetron, a 5-HT3 antagonist, in benzodiazepine discontinuation.

1 reference

12 December 2020

Benzodiazepine-induced persisting amnestic disorder: are older adults at risk?

1 reference

12 December 2020

Practice guideline for the treatment of patients with panic disorder. Work Group on Panic Disorder. American Psychiatric Association

1 reference

12 December 2020

Single-dose pharmacokinetics and pharmacodynamics of alprazolam in elderly and young subjects

1 reference

12 December 2020

A neuropsychological study of panic disorder: negative findings

1 reference

12 December 2020

The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation.

1 reference

12 December 2020

Effect of venlafaxine on the pharmacokinetics of alprazolam.

1 reference

12 December 2020

A double-blind trial of four medications to treat severe premenstrual syndrome

1 reference

12 December 2020

Functional magnetic resonance imaging of alprazolam-induced changes in humans with familial alcoholism

1 reference

12 December 2020

Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences

1 reference

12 December 2020

Effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of alprazolam

1 reference

12 December 2020

Alprazolam 0.125 mg Twice a Day Improves Aspects of Psychometric Performance in Healthy Volunteers

1 reference

12 December 2020

Association of road-traffic accidents with benzodiazepine use.

1 reference

12 December 2020

Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam.

1 reference

12 December 2020

Behavioral effects of alprazolam in humans.

1 reference

12 December 2020

Behavioral contingencies modulate alprazolam self-administration by humans.

1 reference

12 December 2020

Panic disorder: long-term pharmacotherapy and discontinuation

1 reference

12 December 2020

10.1111/J.1527-3458.2004.TB00003.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978513%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978513%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

PubMed publication ID

14978513

1 reference